The California State Auditor’s office released a report on home-generated sharps and pharmaceutical waste disposal as directed by the Joint Legislative Audit Committee. The official request was to gather data on relevant laws and regulations, consumer education, current programs and their efficacy, best practices from other jurisdictions, volume of waste, and more.
New Digital Advocacy “Take Action” Center helps members stay informed about CLSA’s advocacy efforts, view priority legislation, contact their elected officials and more.
CLSA member companies have noted with growing urgency that transportation issues are a top concern for business. CLSA has taken the lead in working with many local and regional transportation collaborations to give voice to our industry’s perspective and seek solutions for our companies.
While the County of Los Angeles in Southern California deliberates over take-back legislation, the number of Counties in Northern California to pass take-back ordinances continues to grow.
CLSA continues to advocate for solutions to the Silicon Valley-Bay Area transportation gridlock as part of the C3 coalition so our member company employees can more easily commute.
In 2017, CLSA will continue to direct and expand its one-of-a-kind locally-focused program throughout the state. California has 58 Counties, and 482 municipalities, each with its own governmental role and procedures. CLSA actively monitors and responds to legislation in each of these jurisdictions as appropriate for our members.
The entire San Francisco Bay Area will have county-by-county based drug takeback ordinances by early 2017.
Elections in the Bay Area’s Counties and Cities have their mark on the local landscape.
CLSA is pleased to provide you with this exclusive 2016 local election update, and what these results mean for California’s life sciences sector.
This November, the citizens of the County of Sonoma will vote on a measure to ban genetically modified organisms (GMO’s) in the County.